Alexandre Sostelly

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

Alexander Röth, J Nishimura, Zsolt Nagy et al. · Blood · 2020 · 130 citations · Full text

Life Sciences, Hematology, Immunology +12

Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma

MS Chatterjee, Jeroen Elassaiss‐Schaap, Andreas Lindauer et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 82 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Efficacy and safety of the <scp>C5</scp> inhibitor crovalimab in complement inhibitor‐naive patients with <scp>PNH</scp> (<scp>COMMODORE</scp> 3): A multicenter, <scp>Phase</scp> 3, single‐arm study

Hui Liu, Linghui Xia, Jianyu Weng et al. · American Journal of Hematology · 2023 · 38 citations · Full text

Medicine, Hematology, Pharmacology +15

Tumor Static Concentration Curves in Combination Therapy

Tim Cardilin, J.O. Almquist, Mats Jirstrand et al. · The AAPS Journal · 2016 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

OP0224 RESULTS OF A PHASE 2 STUDY OF RG6125, AN ANTI-CADHERIN-11 MONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO ANTI-TNFALPHA THERAPY

Rebecca Finch, Alexandre Sostelly, Kim Sue-Ling et al. · Annals of the Rheumatic Diseases · 2019 · 23 citations · Full text

Medicine, Immunology, Pharmacotherapy +17